These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Owen CE Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005 [TBL] [Abstract][Full Text] [Related]
4. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Chang TW; Wu PC; Hsu CL; Hung AF Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539 [TBL] [Abstract][Full Text] [Related]
5. [Progress in the study of allergic disease drugs targeting on IgE/FcepsilonRI signaling pathway]. Liu ZC; Shi HL; Zhang YF; Zhao LJ Yao Xue Xue Bao; 2011 Oct; 46(10):1161-6. PubMed ID: 22242444 [TBL] [Abstract][Full Text] [Related]
6. [Pathophysiological and pharmacotherapeutic aspects of IgE-mediated allergic reactions]. Simon HU Ther Umsch; 2001 May; 58(5):266-73. PubMed ID: 11407226 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases]. Bobrowska M; Stelmach I Pneumonol Alergol Pol; 2004; 72(1-2):70-4. PubMed ID: 15757296 [No Abstract] [Full Text] [Related]
8. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology. Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583 [TBL] [Abstract][Full Text] [Related]
9. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma. Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078 [TBL] [Abstract][Full Text] [Related]
10. IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment. Zellweger F; Eggel A Allergy; 2016 Dec; 71(12):1652-1661. PubMed ID: 27709638 [TBL] [Abstract][Full Text] [Related]
11. Anti-allergic effects of phlorotannins on histamine release via binding inhibition between IgE and Fc epsilonRI. Li Y; Lee SH; Le QT; Kim MM; Kim SK J Agric Food Chem; 2008 Dec; 56(24):12073-80. PubMed ID: 19053379 [TBL] [Abstract][Full Text] [Related]
12. Vaccines targeting IgE in the treatment of asthma and allergy. Peng Z Hum Vaccin; 2009 May; 5(5):302-9. PubMed ID: 19221515 [TBL] [Abstract][Full Text] [Related]
13. IgE inhibition as a therapy for allergic disease. Jardieu PM; Fick RB Int Arch Allergy Immunol; 1999; 118(2-4):112-5. PubMed ID: 10224354 [TBL] [Abstract][Full Text] [Related]
14. Design of peptides derived from anti-IgE antibody for allergic treatment. Takahashi M; Ohgitani Y; Ueno A; Mihara H Bioorg Med Chem Lett; 1999 Aug; 9(15):2185-8. PubMed ID: 10465542 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for non-human primate type-I hypersensitivity: antigen-specific immunoglobulin E assays. Clark D; Shiota F; Forte C; Narayanan P; Mytych DT; Hock MB J Immunol Methods; 2013 Jun; 392(1-2):29-37. PubMed ID: 23541488 [TBL] [Abstract][Full Text] [Related]
16. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro. Heneberg P; Riegerová K; Kučera P PLoS One; 2015; 10(11):e0142953. PubMed ID: 26562153 [TBL] [Abstract][Full Text] [Related]
17. [Anti-IgE--a new treatment for allergic diseases]. Berkun Y; Shalit M Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220 [TBL] [Abstract][Full Text] [Related]
18. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy. Poole JA; Matangkasombut P; Rosenwasser LJ J Allergy Clin Immunol; 2005 Mar; 115(3):S376-85. PubMed ID: 15753882 [No Abstract] [Full Text] [Related]
19. Developing antibodies for targeting immunoglobulin and membrane-bound immunoglobulin E. Chang TW Allergy Asthma Proc; 2006; 27(2 Suppl 1):S7-14. PubMed ID: 16722326 [TBL] [Abstract][Full Text] [Related]